The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,927 | -771 | 2,209 | -996 | -14,322 |
| Depreciation Amortization | 3,394 | 2,474 | 1,606 | 795 | 3,238 |
| Income taxes - deferred | -1,242 | -3,538 | 221 | 221 | -1,344 |
| Accounts receivable | -2,195 | -4,195 | -1,794 | -550 | -6,763 |
| Accounts payable and accrued liabilities | 2,916 | 6,250 | 951 | 474 | 3,758 |
| Other Working Capital | -14,489 | -1,809 | -4,887 | 402 | 992 |
| Other Operating Activity | -10,137 | -7,756 | -4,972 | 118 | 14,949 |
| Operating Cash Flow | $-32,680 | $-9,345 | $-6,666 | $464 | $508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,847 | -1,976 | -1,026 | -619 | -1,194 |
| Net Acquisitions | -9,107 | -827 | -827 | -827 | -150 |
| Purchase Sale Intangibles | -200 | -200 | -200 | N/A | N/A |
| Other Investing Activity | -200 | -200 | -200 | 0 | -7,500 |
| Investing Cash Flow | $-12,154 | $-3,003 | $-2,053 | $-1,446 | $-8,844 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,500 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 12,493 |
| Debt Repayment | -7,251 | -2,118 | -2,110 | -104 | -312 |
| Common Stock Issued | N/A | 0 | N/A | N/A | 50 |
| Other Financing Activity | 161,261 | 20,000 | 20,000 | 20,000 | -343 |
| Financing Cash Flow | $154,010 | $17,882 | $17,890 | $22,396 | $11,888 |
| Beginning Cash Position | 5,998 | 5,998 | 5,998 | 5,998 | 2,446 |
| End Cash Position | 115,174 | 11,532 | 15,169 | 27,412 | 5,998 |
| Net Cash Flow | $109,176 | $5,534 | $9,171 | $21,414 | $3,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,680 | -9,345 | -6,666 | 464 | 508 |
| Capital Expenditure | -2,847 | -1,976 | -1,026 | -619 | -1,194 |
| Free Cash Flow | -35,527 | -11,321 | -7,692 | -155 | -686 |